Johnson & Johnson announced a voluntary withdraw of 57,000 Topamax, a drug used for migraine and epilepsy, because of its unpleasant smell. The notice came from Ortho-McNeil Neurologics, Ortho-McNeil-Janssen Pharmaceuticals’ division, which is a company of Johnson & Johnson that is based in Titusville, New Jersey. Mark Wolfe, the spokesperson of Johnson & Johnson, said [...]


Posted in
Tags:
